Here is PP 2026 Paper 1 solved freshly in a clean, structured format with strict marks distribution:
π MODEL ANSWERS
Pre-University Examination β Physiology Paper I (MBBS Batch 2025-26)
Time: 3 Hours | Theory: 80 Marks | MCQs: 20 Marks | Total: 100 Marks
Attempt all questions. Give diagrams wherever necessary.
βββββββββββββββββββββββββββββββββββββββ
Q.1 β ESSAY TYPE QUESTION
(5 + 4 + 6 = 15 Marks)
(a) Define and Classify Shock β [5 Marks]
Definition:
Shock is a state of acute circulatory failure in which tissue perfusion is inadequate to meet the metabolic demands of cells, leading to cellular hypoxia, organ dysfunction, and if untreated, death.
- Cellular consequence: shift from aerobic β anaerobic metabolism β lactic acidosis β cell death β multi-organ failure (MOF).
Classification:
I. Hypovolemic Shock β β circulating blood volume
| Sub-type | Examples |
|---|
| Hemorrhagic | Trauma, GI bleed, ruptured aneurysm |
| Non-hemorrhagic | Severe dehydration, burns (plasma loss), vomiting/diarrhea, third-space loss |
II. Cardiogenic Shock β pump failure despite adequate volume
- Causes: Acute MI (most common), severe arrhythmias, dilated cardiomyopathy, acute valve rupture.
III. Distributive Shock β pathological vasodilation β maldistribution of flow
| Sub-type | Mechanism |
|---|
| Septic | Bacterial toxins β cytokines (TNF-Ξ±, IL-1) β vasodilation + capillary leak |
| Anaphylactic | IgE-mediated β massive histamine + leukotrienes β vasodilation + β permeability |
| Neurogenic | Spinal cord injury β loss of sympathetic tone β vasodilation + bradycardia |
IV. Obstructive Shock β mechanical obstruction to circulation
- Causes: Massive pulmonary embolism, cardiac tamponade, tension pneumothorax.
Stages of Shock:
- Compensated β compensatory mechanisms maintain BP; patient may be normal clinically.
- Progressive (Decompensated) β mechanisms fail; BP falls; ischemia worsens; positive feedback begins.
- Irreversible (Refractory) β irreversible cellular damage; death despite treatment.
(b) Pathophysiology of Haemorrhagic Shock β [4 Marks]
Trigger: Acute blood loss β β blood volume β β venous return β β preload β β stroke volume β β cardiac output β β arterial BP β β tissue perfusion β hypoxia.
Compensatory Mechanisms (Early/Compensated Phase):
1. Baroreceptor Reflex (seconds):
β BP β β carotid/aortic baroreceptor firing β medullary cardiovascular center β β sympathetic outflow + β vagal tone β tachycardia + vasoconstriction β partial BP restoration.
2. Catecholamine Release (seconds-minutes):
Adrenal medulla β adrenaline + noradrenaline β β HR, β contractility, arteriolar + venous constriction, skin/visceral vasoconstriction (maintains perfusion to heart and brain).
3. RAAS Activation (minutes-hours):
β Renal perfusion β β renin β angiotensin II β aldosterone β NaβΊ/water retention β attempts to restore volume.
4. ADH (Vasopressin) (minutes):
β blood volume + β plasma osmolality β ADH from posterior pituitary β β water reabsorption (V2 receptors, collecting duct) + vasoconstriction (V1 receptors).
5. Transcapillary Fluid Shift (minutes):
Arteriolar vasoconstriction β β capillary hydrostatic pressure β osmotic absorption of interstitial fluid into capillaries β "autotransfusion" (~500 mL possible).
Decompensated Phase (if loss > 30-40%):
- Metabolic acidosis (lactic acid from anaerobic metabolism) β myocardial depression.
- Gut ischemia β mucosal barrier disruption β bacterial translocation β sepsis.
- Microvascular sludging β DIC.
- Visceral vasoconstriction β ischemic organ damage.
Classification by Blood Loss (4 Classes):
| Class | Loss (mL) | % Vol | Features |
|---|
| I | < 750 | < 15% | Minimal; no BP change |
| II | 750-1500 | 15-30% | Tachycardia, anxiety |
| III | 1500-2000 | 30-40% | Hypotension, oliguria, confusion |
| IV | > 2000 | > 40% | Life-threatening; anuria |
(c) Refractory Shock + Positive Feedback Mechanisms β [6 Marks]
Definition of Refractory (Irreversible) Shock:
A stage of shock in which the circulatory failure is so severe and prolonged that irreversible cell and organ damage has occurred and the patient cannot survive even with maximal therapeutic intervention (fluids, vasopressors, blood products).
- Characterized by: multi-organ failure (heart, kidney, liver, lungs, brain), DIC, profound acidosis.
Positive Feedback (Vicious Cycle) Mechanisms:
1. Cardiac Depression Cycle:
β BP β β coronary perfusion β myocardial ischemia
β β contractility β β CO β further β BP β more ischemia β cardiac failure
2. Metabolic Acidosis Cycle:
Tissue ischemia β anaerobic metabolism β lactic acid β metabolic acidosis
β inhibits vasomotor center β vasodilation β β BP β more ischemia β more acidosis
3. Gut Ischemia β Sepsis Cycle:
Prolonged gut hypoperfusion β intestinal mucosal barrier disruption
β bacterial/endotoxin translocation β systemic sepsis
β cytokine storm (TNF-Ξ±, IL-1, IL-6) β further vasodilation β multi-organ failure
4. Capillary Sludging β DIC Cycle:
Endothelial damage + acidosis β RBC/platelet aggregation
β microthrombi β capillary plugging β β tissue perfusion
β more ischemia β DIC (disseminated intravascular coagulation)
5. Cerebral Ischemia Cycle:
Severe β BP β cerebral ischemia β vasomotor center failure
β loss of sympathetic tone β profound vasodilation β BP collapses β brain death
(Cushing reflex initially compensates, but eventually fails)
6. Capillary Leak Cycle:
Hypoxia + cytokines β endothelial cell damage β β capillary permeability
β plasma leaks into interstitium β β blood volume β β preload β β CO β β BP β more endothelial damage
Clinical significance: Once these positive feedback loops are established, they reinforce each other making shock self-perpetuating and unresponsive to treatment β the basis of irreversibility.
βββββββββββββββββββββββββββββββββββββββ
Q.2 β CLINICAL CASE SCENARIO
(2 + 5 + 6 + 2 = 15 Marks)
Case: 35-year-old woman, mother of 3 children. Complaints: dizziness, weakness, easy fatigability, shortness of breath on minimal exertion. Examination: conjunctival pallor, brittle spoon-shaped nails (koilonychia), malnourished. Investigations: RBC = 3 million/cu mm (low), Hb = 7 g/dL (low).
(a) Probable Diagnosis β [2 Marks]
Diagnosis: Iron Deficiency Anemia (IDA)
Supporting evidence:
| Feature | Significance |
|---|
| Koilonychia (spoon-shaped nails) | Pathognomonic of iron deficiency |
| Conjunctival pallor | Anemia |
| Fatigue, dizziness, exertional dyspnea | Classic anemia symptoms (β Oβ delivery) |
| Hb 7 g/dL (normal female: 12-16 g/dL) | Severe anemia |
| RBC 3 million (normal female: 4.2-5.4 million) | Reduced red cell count |
| Mother of 3 children, malnourished | β Iron demands in pregnancy + poor dietary intake |
| Fertile age female | Menstrual blood loss as additional cause |
(b) Findings in Peripheral Blood Smear β [5 Marks]
In iron deficiency anemia, the peripheral smear shows:
1. Microcytes:
- RBCs smaller than normal (MCV < 80 fL).
- Smaller than the nucleus of a small lymphocyte.
2. Hypochromia:
- Central pallor zone > 1/3 of RBC diameter.
- MCHC < 32 g/dL β less Hb per cell due to iron deficiency.
3. Anisocytosis:
- Variation in RBC size β increased RDW (> 14.5%).
4. Poikilocytosis:
- Variation in RBC shape:
- Pencil cells (cigar cells) β elongated, thin RBCs; most characteristic of IDA.
- Target cells (occasional).
- Elliptocytes.
5. Reticulocytopenia:
- Low reticulocyte count β inadequate bone marrow response due to iron lack.
- (After iron therapy β reticulocyte count rises in 5-10 days β therapeutic confirmation.)
6. Reactive Thrombocytosis:
- Increased platelet count β common in IDA (iron deficiency stimulates thrombopoiesis via shared erythroid/megakaryocytic precursors).
7. Normal WBC morphology:
- White cells unaffected in pure IDA.
(c) Other Investigations β [6 Marks]
A. Confirm Anemia Type β CBC:
| Test | Finding in IDA | Normal |
|---|
| MCV | < 80 fL (microcytic) | 80-100 fL |
| MCH | < 27 pg | 27-32 pg |
| MCHC | < 32 g/dL | 32-36 g/dL |
| RDW | β > 14.5% | 11.5-14.5% |
B. Iron Studies (Confirm IDA):
| Test | Finding in IDA | Normal |
|---|
| Serum Iron | Decreased (< 60 Β΅g/dL) | 60-170 Β΅g/dL |
| TIBC (Total Iron Binding Capacity) | Increased (> 400 Β΅g/dL) | 250-370 Β΅g/dL |
| Transferrin Saturation (Fe/TIBC Γ 100) | Decreased (< 16%) | 20-50% |
| Serum Ferritin | Decreased (< 12 ng/mL) | 15-200 ng/mL |
Serum Ferritin is the single best test β reflects total body iron stores; first to fall in iron depletion.
C. Find the Cause of Iron Deficiency:
- Stool for occult blood β rule out GI blood loss (peptic ulcer, colorectal cancer).
- Stool for ova and cysts β hookworm infestation (major cause in India).
- Upper GI endoscopy / Colonoscopy β if GI bleed suspected.
- Urine examination β hemoglobinuria (hemolytic causes).
- Menstrual history β menorrhagia as cause.
D. Bone Marrow Examination (Gold Standard β if diagnosis unclear):
- Absent Prussian blue (Perl's) staining of iron stores.
- Erythroid hyperplasia with micronormoblasts.
- (Rarely needed if iron studies are clear.)
E. Exclude Other Causes / Mixed Deficiency:
- Serum B12 and Folate β rule out combined deficiency (dimorphic picture on smear).
- Thyroid function tests β hypothyroidism can coexist.
- Reticulocyte count β low in IDA; useful to monitor treatment response.
(d) Well-labelled Diagram β Stages of Erythropoiesis β [2 Marks]
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β STAGES OF ERYTHROPOIESIS β
β (Bone Marrow β Peripheral Blood) β
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
PLURIPOTENT STEM CELL (Hemocytoblast)
β
COMMON MYELOID PROGENITOR
β
BFU-E β CFU-E (Committed Erythroid Progenitors)
β β EPO (Erythropoietin) acts here
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β PROERYTHROBLAST (Pronormoblast) β
β β’ Largest cell (~20 Β΅m) β
β β’ Large nucleus, prominent nucleoli β
β β’ Basophilic cytoplasm (rich in ribosomes) β
β β’ Hb synthesis BEGINS β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β BASOPHILIC ERYTHROBLAST (Early Normoblast) β
β β’ Deep blue cytoplasm (RNA/ribosomes) β
β β’ Active Hb synthesis β
β β’ Nucleus: smaller, chromatin coarser β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β POLYCHROMATOPHILIC ERYTHROBLAST (Int. Normoblast) β
β β’ Cytoplasm: BOTH blue (RNA) + pink (Hb) β
β β’ Nucleus: shrinking, chromatin condensing β
β β’ Hb accumulating rapidly β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β ORTHOCHROMATIC ERYTHROBLAST (Late Normoblast) β
β β’ Cytoplasm: predominantly PINK (full of Hb) β
β β’ Nucleus: small, pyknotic β EXTRUDED here β
β β Last stage capable of mitosis β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β (nucleus extruded)
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β RETICULOCYTE β
β β’ No nucleus; residual RNA (blue with supravital β
β stain β New Methylene Blue) β
β β’ 1-2% of circulating RBCs (normal) β
β β’ Matures to RBC in 1-2 days in blood β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β MATURE ERYTHROCYTE (RBC) β
β β’ Biconcave disc, 7-8 Β΅m diameter β
β β’ No nucleus, no organelles β
β β’ Hb = 29 pg/cell (MCH) β
β β’ Lifespan: 120 days β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββ
Key changes during maturation:
Cell SIZE: β (20 Β΅m β 7 Β΅m)
Nucleus: Present β Shrinks β Pyknotic β EXTRUDED
Cytoplasm: Basophilic (blue) β Polychromatic β Acidophilic (pink)
Hb: Absent β ββ progressively
Organelles: Lost progressively
βββββββββββββββββββββββββββββββββββββββ
Q.3 β SHORT NOTES (Maximum 500 words each)
(5 Γ 6 = 30 Marks)
(a) Short-term Regulation of Blood Pressure β [6 Marks]
Short-term regulation acts within seconds to minutes via neural and humoral mechanisms. Goal: rapidly restore BP to normal after acute perturbation.
1. Baroreceptor (Pressoreceptor) Reflex β most important (seconds):
Receptors: Stretch-sensitive mechanoreceptors in:
- Carotid sinus (CN IX β Hering's nerve) β most sensitive.
- Aortic arch (CN X β Vagus).
When BP rises:
β BP β β Baroreceptor stretch β β Afferent firing (CN IX/X)
β NTS (Nucleus Tractus Solitarius, medulla)
β β Vagal tone (β HR) + β Sympathetic tone (vasodilation, β contractility)
β β CO + β TPR β BP FALLS back toward normal
When BP falls:
β BP β β Baroreceptor firing β NTS
β β Vagal tone + β Sympathetic outflow
β β HR + β contractility + Vasoconstriction
β β CO + β TPR β BP RISES back toward normal
Limitation: Resets to new set-point in chronic hypertension (baroreceptors adapt β no longer fight elevated BP).
2. Chemoreceptor Reflex (seconds-minutes):
Peripheral chemoreceptors (carotid + aortic bodies):
- Detect: β PaOβ (< 60 mmHg), β PaCOβ, β pH.
- Response: β Vasomotor center activation β vasoconstriction β β BP.
Central chemoreceptors (ventral medullary surface):
- Detect: β COβ/HβΊ in CSF.
- Response: β Sympathetic activation β β BP + β ventilation.
3. CNS Ischemic Response (Cushing Reflex) β emergency mechanism:
- Trigger: Severe β cerebral perfusion (MAP < 60 mmHg OR β ICP).
- COβ accumulates in medullary vasomotor center β most powerful sympathetic activation β extreme vasoconstriction + β HR β massive β BP.
- Cushing's Triad (late sign of β ICP): Hypertension + Bradycardia (baroreceptor reflex to high BP) + Irregular breathing.
4. Bainbridge Reflex:
- β Venous return β right atrial distension β stretch receptors β reflex tachycardia (sympathetic).
- Prevents venous pooling when filling pressure rises.
5. Adrenal Medullary Response (30 seconds-minutes):
- Sympathetic stimulation β adrenal medulla β Adrenaline (β HR, β CO) + Noradrenaline (vasoconstriction).
- Amplifies and sustains the sympathetic response.
Summary Table:
| Mechanism | Speed | Trigger | Effect |
|---|
| Baroreceptor reflex | Seconds | BP change | Buffer/normalize |
| Chemoreceptor reflex | Seconds-min | Hypoxia/hypercapnia | β BP via vasoconstriction |
| Cushing reflex | Seconds | Cerebral ischemia | Emergency β BP |
| Bainbridge reflex | Seconds | β Venous return | β HR |
| Adrenal medulla | 30 sec-min | Sympathetic activation | β HR, β BP |
(b) Pacemaker Potential β Diagram and Ionic Basis β [6 Marks]
Definition:
The pacemaker potential (prepotential / slow diastolic depolarization) is the spontaneous, gradual self-depolarization of SA node cells during Phase 4 (diastole) that brings the membrane potential from its maximum diastolic potential (MDP) to threshold, triggering each action potential. It is the cellular basis of cardiac automaticity.
Key Values:
- Maximum Diastolic Potential (MDP): ~ β60 mV
- Threshold: ~ β40 mV
- Normal SA node firing rate: 60-100 beats/min
- No stable resting potential (unlike neurons or skeletal muscle)
Diagram of SA Node Action Potential:
Voltage
(mV)
+20 βββββββββββββββββββββββββββββββββββββββββββββββββ
/\ /\
/ \ / \ PHASE 0
/ \ / \ (L-type CaΒ²βΊ influx β upstroke)
0 βββββββββ / \ / \ ββββββββββββββββββ
/ \/ \
-40 βββββββ/ββββββββββββββββββββββ \ββββββββββββββ
β β THRESHOLD \
/ Phase 4 \ Phase 3
-60 βββ/βββββββββββββββββββββββββββββ\ββββββββββββ
MDP β β
(Start of pacemaker (Repolarization
potential) complete)
βββββ PHASE 4 βββββββββββββββββ
(Pacemaker/prepotential)
Ionic Basis of Phase 4 (Pacemaker Potential) β THREE Key Currents:
1. Funny Current (If) β Most Important:
- Channel: HCN channels (Hyperpolarization-activated, Cyclic Nucleotide-gated).
- Activated at: Hyperpolarized potentials (opens at β60 mV MDP after repolarization).
- Ion: Mixed NaβΊ and KβΊ inward current β net depolarizing.
- Called "funny": Unusual β most channels close at negative potentials, HCN channels open.
- cAMP modulation:
- Sympathetic (Ξ²β) β β cAMP β shifts If activation to more positive voltages β steeper slope β tachycardia.
- Vagal (Mβ) β β cAMP β shifts If to more negative voltages β slower slope β bradycardia.
- Drug: Ivabradine selectively blocks HCN/If channels β pure heart rate reduction (used in chronic stable angina, heart failure with tachycardia).
2. Decreasing KβΊ Outward Current (IK decay):
- After repolarization, delayed rectifier KβΊ channels (IKr, IKs) gradually close.
- β KβΊ efflux β membrane becomes less negative β contributes to slow depolarization.
3. T-type CaΒ²βΊ Channels (transient/low-threshold):
- Activated as membrane approaches ~ β50 mV (late Phase 4).
- Transient CaΒ²βΊ influx β accelerates depolarization toward threshold.
- Provides the final "push" to threshold.
Phases of SA Node Action Potential:
| Phase | Ion Current | Event |
|---|
| Phase 4 | If β, IK β, T-CaΒ²βΊ β | Pacemaker potential (slow spontaneous depolarization) |
| Phase 0 | L-type CaΒ²βΊ influx (not NaβΊ!) | Upstroke β slow, CaΒ²βΊ-dependent (no fast NaβΊ channels in SA node) |
| Phase 3 | IKr/IKs (KβΊ efflux) | Repolarization back to MDP |
(Note: SA node has NO Phase 1, Phase 2 β no plateau; no fast NaβΊ channels)
Autonomic Modulation:
SYMPATHETIC (Ξ²β receptors) β β cAMP β β If + β ICaL
β Steeper Phase 4 slope + higher MDP
β AP fires SOONER β TACHYCARDIA
PARASYMPATHETIC (Mβ receptors) β β cAMP + β IKACh (KβΊ efflux)
β Flatter Phase 4 slope + more negative MDP
β AP fires LATER β BRADYCARDIA
(c) Regulation of Respiration by Carotid and Aortic Bodies β [6 Marks]
These are: Peripheral Chemoreceptors
They are the only receptors that respond to hypoxemia (low PaOβ) β central chemoreceptors do NOT respond to Oβ levels.
Location and Anatomy:
Carotid Bodies:
- Location: Bifurcation of common carotid artery (bilaterally).
- Afferent: Hering's nerve β CN IX (Glossopharyngeal) β NTS, medulla.
- Highest blood flow per gram of any tissue (ensures rapid detection of arterial blood changes).
- Cells: Type I (glomus) cells β chemosensitive; contain dopamine, substance P, ACh.
- Type II (sustentacular) cells β supportive, glial-like.
Aortic Bodies:
- Location: Aortic arch region.
- Afferent: CN X (Vagus) β NTS, medulla.
- Less important than carotid bodies in humans for respiratory control.
Stimuli Detected:
| Stimulus | Threshold | Significance |
|---|
| β PaOβ | < 60 mmHg (strong stimulus) | Hypoxic ventilatory response |
| β PaCOβ | Any rise | Moderate stimulus |
| β pH (β HβΊ) | Any fall | Direct HβΊ sensing |
| β Blood flow (stagnant hypoxia) | β | Simulates extreme ischemia |
Mechanism of Chemotransduction (Type I cells):
β PaOβ in arterial blood
β
Type I glomus cells detect βOβ
β
Oβ-sensitive KβΊ channels CLOSE β KβΊ efflux blocked
β
MEMBRANE DEPOLARIZES
β
Voltage-gated CaΒ²βΊ channels open β CaΒ²βΊ influx
β
Neurotransmitter release (Dopamine, Substance P, ATP, ACh)
β
Activates afferent nerve endings
β
CN IX β NTS β Respiratory + Cardiovascular centers (medulla)
β
β Respiratory rate and depth (hyperventilation)
+ Peripheral vasoconstriction (cardiovascular response)
Ventilatory Responses:
Response to β PaOβ:
- Ventilation increases significantly only when PaOβ falls below 60 mmHg (on steep part of Oβ-Hb dissociation curve).
- Above 60 mmHg: moderate hypoxemia has little effect (flat part of curve).
- Below 60 mmHg: small further fall β large β in ventilation (hypoxic ventilatory response, HVR).
Response to β PaCOβ:
- Peripheral chemoreceptors respond but central chemoreceptors are the primary COβ sensors.
- Carotid bodies augment the central response.
Synergism: Hypoxia + hypercapnia together β synergistic (more than additive) increase in ventilation.
Clinical Applications:
1. High Altitude Acclimatization:
- β PaOβ at altitude β peripheral chemoreceptors β β ventilation β β PaCOβ (respiratory alkalosis initially) β over days: renal HCOββ» compensation β sustained hyperventilation.
2. COPD β Hypoxic Drive:
- In chronic COβ retainers (COPD with chronic hypercapnia) β central chemoreceptors reset (adapted to high COβ) β patient relies on hypoxic drive (peripheral chemoreceptors, carotid bodies) for breathing stimulus.
- Danger: Giving high-flow Oβ β corrects hypoxia β removes hypoxic drive β respiratory depression β hypercapnic coma (COβ narcosis).
- Management: Controlled low-flow Oβ (target SpOβ 88-92% in known COPD).
3. Cheyne-Stokes Breathing:
- Impaired peripheral + central chemoreceptor integration β oscillatory breathing pattern in heart failure, CNS disease.
(d) Composition of Pancreatic Juice + Why Autodigestion Does Not Occur β [6 Marks]
Composition of Pancreatic Juice:
- Daily volume: ~1.5 litres/day
- pH: 8.0-8.3 (alkaline β due to HCOββ»)
- Produced by: Acinar cells (enzymes) + Ductal cells (water + HCOββ»)
Table of Components:
| Component | Secreted As | Activated By | Function |
|---|
| Trypsinogen | Proenzyme (inactive) | Enterokinase in duodenum β Trypsin | Digests proteins (cleaves Arg, Lys peptide bonds) |
| Chymotrypsinogen | Proenzyme | Trypsin β Chymotrypsin | Digests proteins (cleaves aromatic AA bonds) |
| Proelastase | Proenzyme | Trypsin β Elastase | Digests elastin and other proteins |
| Procarboxypeptidase A & B | Proenzyme | Trypsin β Carboxypeptidase | Cleaves C-terminal amino acids |
| Phospholipase Aβ | Proenzyme | Trypsin β active form | Digests phospholipids |
| Pancreatic lipase | Active | (Not a proenzyme) | Digests TG β 2-monoglycerides + FFA (needs colipase) |
| Colipase | Proenzyme | Trypsin β active | Anchors lipase to fat droplet surface |
| Pancreatic amylase | Active | (Not a proenzyme) | Digests starch β maltose, maltotriose |
| Ribonuclease / DNase | Active | β | Digest nucleic acids |
| NaHCOβ | β | β | Neutralizes gastric acid; provides alkaline pH |
| Trypsin Inhibitor (PSTI) | β | β | Inhibits premature trypsin activation |
Regulation:
- Secretin (from S cells, duodenum, triggered by HβΊ) β ductal cells β large volume HCOββ»-rich juice.
- CCK (from I cells, duodenum, triggered by fats + proteins) β acinar cells β enzyme-rich juice.
- Vagus (ACh): Cephalic phase β enzyme secretion.
Why Autodigestion Does NOT Occur β 6 Protective Mechanisms:
1. Synthesis as Inactive Proenzymes (Zymogens):
- All proteases are synthesized and stored as inactive precursors (trypsinogen, chymotrypsinogen, proelastase, procarboxypeptidase, phospholipase Aβ).
- Cannot digest tissue until activated.
2. Activation Requires Enterokinase (Outside the Pancreas):
- The activation cascade begins ONLY when enterokinase (enteropeptidase) β a brush-border enzyme of the duodenal mucosa β cleaves trypsinogen β trypsin.
- Trypsin then activates all other proenzymes.
- Enterokinase is absent within the pancreas β cascade cannot start inside.
3. Pancreatic Secretory Trypsin Inhibitor (PSTI / SPINK1):
- Co-secreted with zymogens by acinar cells.
- Immediately binds and inhibits any trypsin accidentally activated within the pancreas (handles up to 20% of potential trypsin activity).
- First line of defense against premature activation.
4. Compartmentalization (Subcellular Segregation):
- Zymogens are stored in membrane-bound zymogen granules within acinar cells.
- Kept strictly separated from lysosomal hydrolases (if they mix β autoactivation can occur β a mechanism in pancreatitis).
5. Low Intracellular pH:
- pH inside zymogen granules is acidic β inhibits premature enzyme activation.
- Optimal pH for trypsin activation is neutral-alkaline (achieved only in duodenal lumen).
6. Mucous Lining of Ducts:
- Pancreatic duct epithelium is coated with mucus β physical barrier against enzyme-mediated self-digestion.
Failure β Acute Pancreatitis:
- Premature intrapancreatic trypsin activation (from gallstone obstruction, alcohol, hypertriglyceridemia, trauma) β cascade activation β autodigestion β severe hemorrhagic pancreatitis β fat necrosis β systemic inflammatory response β potentially fatal.
(e) Movements of Small Intestine β [6 Marks]
The small intestine performs both mixing and propulsive movements coordinated by the Enteric Nervous System (ENS) β the "gut brain."
1. Segmentation β Primary Mixing Movement
- Nature: Non-propulsive; mixes but does not advance content.
- Mechanism: Circular muscle contracts simultaneously at multiple separated points along the intestine β divides content into segments β relaxes β adjacent segments contract β remixes the segmented content repeatedly.
- Rate: ~12 contractions/min in duodenum; ~8/min in ileum (aborad frequency gradient β itself contributes to slow net aboral propulsion).
- Function: Thorough mixing of chyme with digestive enzymes and bile; maximizes contact of digested nutrients with absorptive villi.
- Control: Pacemaker cells β Interstitial Cells of Cajal (ICC) set the slow wave frequency; ENS (myenteric plexus) modulates.
- Initiated by: Intestinal distension by food.
2. Peristalsis β Primary Propulsive Movement
- Nature: Propulsive β advances content aborally (toward large intestine).
- Mechanism β The Peristaltic Reflex (Law of Intestine):
Bolus distends a segment
β
Sensory neurons detect stretch β Myenteric plexus activated
β
ORAL (proximal) side: ABORAL (distal) side:
Circular muscle CONTRACTS + Circular muscle RELAXES
Longitudinal muscle RELAXES Longitudinal muscle CONTRACTS
(ring of contraction behind) (widening/shortening ahead)
β
Net: Bolus propelled aborally
- Neurotransmitters: ACh (contraction, proximal) + VIP/NO (relaxation, distal).
- Speed: Slow (~2-4 cm/sec in small intestine).
- Initiated by: Distension, mucosal irritation, chemical stimuli.
3. Migrating Motor Complex (MMC) β "Intestinal Housekeeper"
- Occurs: During fasting (interdigestive period); abolished when food is eaten.
- Cycle: Every ~90 minutes, organized waves of activity sweep from stomach to terminal ileum.
- Phases:
- Phase I: Quiescence (45-60 min).
- Phase II: Irregular contractions (30 min).
- Phase III: Intense, regular contractions (5-10 min) β the "housekeeper wave" that sweeps everything distally.
- Phase IV: Brief transition back to quiescence.
- Function: Sweeps residual food, bacteria, desquamated cells, and secretions from small intestine into colon between meals. Prevents bacterial overgrowth.
- Control: Motilin (from M cells in duodenum/jejunum) initiates Phase III of MMC.
- Clinical: Erythromycin (antibiotic) mimics motilin β used as prokinetic agent to stimulate gastric emptying and intestinal motility.
4. Pendular Movements
- Rhythmic contractions of longitudinal muscle β intestinal loops swing back and forth like a pendulum.
- Assists in mixing; more prominent in lower animals.
5. Villous Movements
- Individual intestinal villi contract and extend rhythmically (muscularis mucosae contractions).
- Function: "Milking" action β squeezes absorbed nutrients into lacteals and capillaries; enhances lymph (chyle) flow.
- Controlled by local neural reflexes in submucosal plexus.
Summary Table:
| Movement | Type | Function | Control |
|---|
| Segmentation | Mixing | Mix chyme + digestive juices | ICC pacemakers + ENS |
| Peristalsis | Propulsive | Advance content aborally | ENS (myenteric plexus) |
| MMC | Propulsive (fasting) | "Housekeeping" between meals | Motilin + ENS |
| Pendular | Mixing | Mixing (minor) | ENS |
| Villous | Local | Enhance absorption/lymph flow | Submucosal plexus |
βββββββββββββββββββββββββββββββββββββββ
Q.4 β VERY SHORT QUESTIONS (Maximum 300 words each)
(5 Γ 4 = 20 Marks)
(a) Secondary Active Transport vs. Facilitated Diffusion β [4 Marks]
Definition:
- Secondary Active Transport: Movement of a substance against its concentration gradient using the electrochemical gradient of another ion (usually NaβΊ) β energy is indirect (ATP not used directly).
- Facilitated Diffusion: Movement of a substance down its concentration gradient via a specific carrier protein or channel β passive, no ATP required.
Comparison Table:
| Feature | Secondary Active Transport | Facilitated Diffusion |
|---|
| Energy | Indirect (NaβΊ gradient built by NaβΊ/KβΊ-ATPase) | No energy (passive) |
| Direction | Against concentration gradient (uphill) | Down concentration gradient (downhill) |
| ATP directly used | No | No |
| Protein involved | Cotransporter (symport or antiport) | Carrier protein or channel |
| Saturation kinetics | Yes (Km, Vmax) | Yes |
| Inhibition by metabolic poisons | Yes (indirectly β by blocking NaβΊ/KβΊ-ATPase) | No |
| Can concentrate substrate | Yes | No |
Examples:
Secondary Active Transport:
| Transporter | Location | Substrates | Type |
|---|
| SGLT1 | Intestinal epithelium | NaβΊ + Glucose (same direction) | Symport |
| SGLT2 | Renal proximal tubule | NaβΊ + Glucose (same direction) | Symport |
| NaβΊ-amino acid transporter | Intestine, kidney PCT | NaβΊ + AA | Symport |
| NaβΊ-CaΒ²βΊ exchanger (NCX) | Heart, kidney | NaβΊ in, CaΒ²βΊ out | Antiport |
| NaβΊ-HβΊ exchanger (NHE) | PCT, intestine | NaβΊ in, HβΊ out | Antiport |
Facilitated Diffusion:
| Transporter | Location | Substrate |
|---|
| GLUT1 | RBCs, brain, placenta | Glucose (down gradient) |
| GLUT2 | Liver, pancreatic Ξ²-cells, intestine | Glucose (bidirectional, low affinity) |
| GLUT4 | Skeletal muscle, adipose | Glucose (insulin-regulated) |
| Aquaporins (AQP) | Many tissues | Water |
Key distinction (Example):
- In intestinal epithelium: Glucose enters apical surface via SGLT1 (secondary active β against gradient, NaβΊ-driven) β exits basolateral surface via GLUT2 (facilitated diffusion β down gradient into blood).
(b) Gibbs-Donnan Equilibrium β [4 Marks]
Definition:
The Gibbs-Donnan equilibrium describes the unequal distribution of diffusible ions across a semipermeable membrane when non-diffusible charged macromolecules (proteins) are confined to one compartment, while small ions can freely cross.
Basis:
- Plasma proteins (mainly albumin, MW ~69 kDa) are negatively charged and cannot cross the capillary membrane.
- Their fixed negative charges on the plasma side attract cations (NaβΊ) and repel anions (Clβ») β unequal distribution.
Rules of Gibbs-Donnan:
- Electrical neutrality must be maintained on each side.
- Product rule at equilibrium: [Cation]plasma Γ [Anion]plasma = [Cation]ISF Γ [Anion]ISF
- e.g., [NaβΊ]pl Γ [Clβ»]pl = [NaβΊ]ISF Γ [Clβ»]ISF
- Side with non-diffusible anion (plasma): more cations, fewer anions than the other side.
Consequences:
1. Unequal Ion Distribution:
| Ion | Plasma (protein side) | Interstitial Fluid | Ratio (plasma/ISF) |
|---|
| NaβΊ | Slightly higher | Lower | ~1.05 |
| KβΊ | Slightly higher | Lower | ~1.05 |
| Clβ» | Slightly lower | Higher | ~0.95 |
| HCOββ» | Slightly lower | Higher | ~0.95 |
2. Donnan Osmotic Effect (Oncotic Pressure):
- More total particles in plasma than ISF (due to both proteins + extra cations) β osmotic pressure difference.
- Contributes to plasma colloid osmotic pressure (oncotic pressure) β 28 mmHg.
- Crucial component of Starling forces β draws water back from interstitium into capillaries at venous end.
3. Effect on Cell Volume:
- RBCs: Hb (non-diffusible) inside β Donnan effect β tendency to accumulate NaβΊ β would cause cell swelling.
- Countered by NaβΊ/KβΊ-ATPase (actively pumps NaβΊ out) β maintains cell volume.
Clinical Significance:
- Hypoalbuminemia (liver failure, nephrotic syndrome, malnutrition) β β plasma proteins β β oncotic pressure + β Donnan effect β β capillary reabsorption β pitting edema.
- Donnan ratio explains why measured plasma electrolytes are slightly different from interstitial fluid levels.
(c) Role of T-lymphocytes in Immunity β [4 Marks]
T-lymphocytes originate from bone marrow stem cells and mature in the thymus (hence "T"). They are the primary mediators of cell-mediated immunity and also regulate humoral immunity.
Major Types and Functions:
1. CD4βΊ Helper T Cells (Th) β "Orchestrators":
- Recognize antigen on MHC Class II molecules on APCs (dendritic cells, macrophages, B cells).
- Secrete cytokines to activate other immune cells.
| Subset | Cytokines | Function |
|---|
| Th1 | IFN-Ξ³, IL-2, TNF-Ξ± | Activate macrophages (intracellular pathogen killing); stimulate CTLs; defense vs. bacteria, viruses, fungi |
| Th2 | IL-4, IL-5, IL-13 | Activate B cells (IgE/IgG class switching); eosinophils; defense vs. parasites; allergy/asthma |
| Th17 | IL-17, IL-22 | Neutrophil recruitment; defense vs. extracellular bacteria + fungi |
| T follicular helper (Tfh) | IL-21 | Help B cells in germinal centers β antibody affinity maturation |
2. CD8βΊ Cytotoxic T Lymphocytes (CTL) β "Killers":
- Recognize antigen on MHC Class I (expressed on ALL nucleated cells).
- Kill: virus-infected cells, cancer cells, transplanted tissue (graft rejection).
- Killing mechanisms:
- Perforin-granzyme pathway: Perforin forms pores in target cell membrane β granzymes (proteases) enter β apoptosis.
- Fas-FasL pathway: FasL on CTL binds Fas on target β programmed cell death.
3. Regulatory T Cells (Tregs):
- Phenotype: CD4βΊCD25βΊFoxP3βΊ.
- Function: Suppress excessive immune responses β prevent autoimmunity and chronic inflammation.
- Secrete: IL-10, TGF-Ξ² (anti-inflammatory).
- Deficiency β autoimmune disease (e.g., IPEX syndrome); excess β immune evasion by tumors.
4. Memory T Cells:
- Long-lived T cells (both CD4βΊ and CD8βΊ subsets) persisting after first antigen exposure.
- On re-exposure: faster, stronger, more prolonged response (immunological memory).
- Basis of vaccination.
Clinical Significance:
| Condition | T-cell Involvement |
|---|
| HIV/AIDS | Destroys CD4βΊ T cells β immunodeficiency β opportunistic infections |
| Organ transplant rejection | CD8βΊ CTLs attack donor MHC class I β acute rejection |
| Autoimmune diseases | Failure of Tregs + autoreactive T cells |
| Cancer immunotherapy | Checkpoint inhibitors (anti-PD-1, anti-CTLA-4) reinvigorate exhausted CTLs |
| Cyclosporine (immunosuppressant) | Inhibits calcineurin β blocks IL-2 production β β T cell activation |
(d) Decompression Sickness β [4 Marks]
Definition:
A condition caused by rapid decrease in environmental pressure, leading to formation of nitrogen gas bubbles in tissues and blood.
Also called: "The Bends" / Caisson disease / Diver's disease.
Physical Basis β Henry's Law:
"The amount of gas dissolved in a liquid is proportional to the partial pressure of that gas above the liquid."
- At depth β β pressure β more Nβ dissolved in blood and tissues.
- Rapid ascent β pressure drops suddenly β Nβ cannot be exhaled fast enough β Nβ comes out of solution β gas bubbles form in tissues.
Susceptibility:
- Deep sea divers (breathing compressed air), caisson workers (tunnels, bridges), aviators (rapid altitude gain in unpressurized aircraft).
Pathophysiology of Bubbles:
Bubbles form in: joints, muscles, bone marrow, spinal cord, brain, lungs, skin, coronary vessels.
Bubbles cause:
- Mechanical compression of nerves and vessels.
- Vascular obstruction (gas embolism).
- Platelet activation β microthrombi.
- Endothelial damage β inflammation.
- Complement activation.
Clinical Features:
Type I β Mild:
- Joints: Deep aching pain ("the bends") β knees, shoulders, hips, elbows.
- Skin: Pruritus, cutis marmorata (mottled skin), rash.
- Lymphatic: Swelling, lymph node tenderness.
Type II β Serious/Neurological:
- Spinal cord: Motor paralysis, sensory loss, bladder/bowel dysfunction.
- Brain: Headache, confusion, visual disturbances, hemiplegia.
- Pulmonary ("Chokes"): Cough, substernal chest pain, dyspnea.
- Inner ear ("Staggers"): Vertigo, tinnitus, deafness.
- Cardiovascular: Gas embolism β MI, cardiac arrest.
Prevention:
- Staged decompression stops during ascent (allows Nβ to off-gas safely via lungs).
- Follow dive tables / dive computer algorithms.
- Avoid repetitive deep dives, alcohol, dehydration.
- "No-decompression limits" for recreational diving.
Treatment:
- Hyperbaric Oxygen (HBO) Recompression in a hyperbaric chamber β definitive treatment:
- Re-compresses β re-dissolves bubbles β controlled slow decompression.
- Oβ replaces Nβ in tissues β accelerates Nβ off-gassing.
- 100% normobaric Oβ (first aid, during transfer to chamber).
- IV fluids, analgesia, neurological support.
- Do NOT delay β early treatment dramatically improves outcomes.
(e) Sliding Filament Theory of Skeletal Muscle Contraction β [4 Marks]
Definition:
Proposed by Huxley and Hanson (1954). States that muscle contraction occurs by thin filaments (actin) sliding over thick filaments (myosin) toward the center of the sarcomere β the filament lengths remain constant, only the sarcomere shortens.
Sarcomere Structure (basis for understanding):
ZβββββI bandβββββA bandβββββββββA bandβββββI bandβββββZ
H zone M-line H zone
βthick onlyβ βthick onlyβ
thin ββββββββββββββββββββββββββββββ thin
- A band: Fixed (thick filaments + overlapping thin) β does NOT change length.
- I band: Thin filaments only β shortens during contraction.
- H zone: Thick filaments only β shortens during contraction.
- Z-lines: Move closer together β sarcomere shortens.
Mechanism β Cross-Bridge Cycle (5 Steps):
Step 1 β Activation (Excitation-Contraction Coupling):
Motor nerve AP β ACh β Nicotinic receptor β end-plate AP
β T-tubules β DHPR (voltage sensor)
β activates RyR1 (ryanodine receptor) on SR
β CaΒ²βΊ RELEASED from sarcoplasmic reticulum (SR)
β [CaΒ²βΊ]cytoplasm rises from 10β»β· M to 10β»β΅ M
Step 2 β CaΒ²βΊ Binding and Active Site Exposure:
CaΒ²βΊ (Γ4) binds Troponin C (TnC) subunit
β Conformational change in Troponin complex
β Troponin I releases actin
β Tropomyosin SHIFTS laterally off actin active sites
β Myosin-binding sites on actin EXPOSED
Step 3 β Cross-bridge Formation (Attachment):
Energized myosin head (carrying ADP + Pi, cocked at 90Β°)
β Attaches to exposed actin active site
β CROSS-BRIDGE FORMED
Step 4 β Power Stroke:
Pi released β ADP released
β Myosin head PIVOTS from 90Β° β 45Β° (swings ~10-15 nm)
β POWER STROKE: pulls thin filament toward M-line
β Force generated: ~1-5 pN per cross-bridge
Step 5 β Detachment and Re-cocking:
New ATP binds myosin head β Cross-bridge DETACHES from actin
β ATP hydrolyzed (ATPase activity): ATP β ADP + Pi
β Myosin head re-cocks back to 90Β° (energized state)
β Ready for next cycle IF CaΒ²βΊ still present
Cycle continues as long as: CaΒ²βΊ elevated + ATP available β repeated cross-bridge cycling β sustained contraction.
Relaxation:
Nerve impulse stops β No more CaΒ²βΊ release
β SERCA (SR CaΒ²βΊ-ATPase) pumps CaΒ²βΊ back into SR (ATP-dependent)
β [CaΒ²βΊ] falls β CaΒ²βΊ dissociates from TnC
β Tropomyosin returns β blocks actin active sites
β No new cross-bridges form β Muscle RELAXES
Rigor Mortis:
- After death β no ATP produced β myosin heads remain bound to actin (cannot detach) β muscles become stiff (rigor mortis, onset 3-4 hours post-death, maximal at 12 hours).
Changes in Bands During Contraction:
| Band/Zone | Change | Reason |
|---|
| A band | No change | Thick filament length constant |
| I band | Shortens | Thin filaments slide inward, less exposed |
| H zone | Shortens/disappears | Thin filaments overlap center |
| Sarcomere | Shortens | Z-lines move closer |
π FINAL MARKS DISTRIBUTION SUMMARY
| Question | Sub-parts | Marks Allocated | Marks |
|---|
| Q.1 | Essay β Shock | | |
| (a) Define and classify shock | 5 | β
|
| (b) Pathophysiology of haemorrhagic shock | 4 | β
|
| (c) Refractory shock + positive feedback mechanisms | 6 | β
|
| Q.1 Total | | 15 |
| Q.2 | Clinical Case β Anemia | | |
| (a) Probable diagnosis | 2 | β
|
| (b) Peripheral blood smear findings | 5 | β
|
| (c) Further investigations | 6 | β
|
| (d) Diagram of erythropoiesis | 2 | β
|
| Q.2 Total | | 15 |
| Q.3 | Short Notes | | |
| (a) Short-term regulation of BP | 6 | β
|
| (b) Pacemaker potential (diagram + ionic basis) | 6 | β
|
| (c) Carotid and aortic body regulation of respiration | 6 | β
|
| (d) Pancreatic juice + why no autodigestion | 6 | β
|
| (e) Movements of small intestine | 6 | β
|
| Q.3 Total | | 30 |
| Q.4 | Very Short Questions | | |
| (a) Secondary active transport vs. facilitated diffusion | 4 | β
|
| (b) Gibbs-Donnan equilibrium | 4 | β
|
| (c) Role of T-lymphocytes | 4 | β
|
| (d) Decompression sickness | 4 | β
|
| (e) Sliding filament theory | 4 | β
|
| Q.4 Total | | 20 |
| GRAND TOTAL (Theory) | | 80 |
Top Scoring Tips:
- Q.1(c) β Name and draw each positive feedback cycle as a flowchart box-arrow format. Examiners give marks per cycle mentioned β aim for all 6.
- Q.2(d) β Erythropoiesis diagram: draw each stage in a box with key features listed. Cell size decreasing and nucleus shrinking are must-include details.
- Q.3(b) β Pacemaker potential: draw the graph with MDP at β60 mV and threshold at β40 mV clearly labeled. Mention ivabradine (blocks If) β impresses examiners.
- Q.3(c) β Always mention the COPD-Oβ therapy danger in your answer β high yield clinical point examiners specifically look for.
- Q.3(d) β List all 6 protective mechanisms against autodigestion point-by-point for full marks.